Shafali Spurling Jeste, MD
Shafali Spurling Jeste, MD joined Children’s Hospital Los Angeles in 2021 as Chief of the Division of Neurology. In this role, she oversees clinical care delivery and quality, strategic planning, recruitment and program development.
A Board-certified pediatric neurologist, Dr. Jeste focuses on developing methods to improve precision in the diagnosis and treatment of neurodevelopmental disorders. She is a prolific researcher whose lab has defined early predictors of autism in at-risk infants, and she has authored and contributed to more than 200 journal papers, editorials, chapters and abstracts. In 2019, she was awarded the Presidential Early Career Award for Scientists and Engineers for her research in early predictors and intervention for genetic neurodevelopmental disorders.
Dr. Jeste holds several national and international leadership positions including the Board of Directors of the American Brain Foundation, Board of Directors of the National Organization for Rare Disorders and the Board of Directors of the International Society for Autism Research. She also is Co-Founder of ACEing Autism, a national nonprofit that uses tennis to help children with autism connect, grow and develop.
Dr. Jeste earned her bachelor’s degree in philosophy from Yale University before obtaining her medical degree from Harvard Medical School. She completed an internship, residency and a fellowship in behavioral child neurology at Boston Children’s Hospital.
Research Lab
KiNDD Lab
Kids with Neurogenetic and Developmental Disabilities (KiNDD) Lab
Education
Harvard Medical School
Boston Children’s Hospital, Behavioral Child Neurology
Boston Children’s Hospital, Behavioral Child Neurology
Boston Children’s Hospital, Behavioral Child Neurology
Accomplishments
Board of Directors, American Brain Foundation
Board of Directors, National Organization for Rare Disorders
Board of Directors, International Society for Autism Research
Research Studies
Two main purposes of the study: (1) to see if social communication of children with TSC can be improved with a short term behavioral intervention (JASPER) and (2) to see if these improvements remain long after the study, and whether they can be observed with electroencephalography (EEG).
To see if eye tracking (ET) or electroencephalogram (EEG) assessments have potential use in future clinical trials of Autism Spectrum Disorders (ASD).
Media
News-Medical - Heterogeneity of autism makes clinical trials difficult, says CHLA expert
American Pediatric Society - The American Pediatric Society announces its new members for 2022
CHLA Press Release
Children’s Hospital Los Angeles Neurologist Honored With Prestigious Research Award
CHLA Blog
Children’s Hospital Los Angeles Leads First Precision Health Trial for Dup15q Syndrome
How Do You Measure Success in Autism Clinical Trials?
New Faculty Spotlight: Shafali Spurling Jeste, MD